Lantern Pharma, Inc. (LTRN)
1.80
-0.04
(-2.17%)
USD |
NASDAQ |
Sep 09, 12:39
Lantern Pharma Total Assets (Quarterly) : 8.602M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.602M |
| March 31, 2026 | 7.223M |
| December 31, 2025 | 11.04M |
| September 30, 2025 | 13.63M |
| June 30, 2025 | 17.42M |
| March 31, 2025 | 21.10M |
| December 31, 2024 | 25.57M |
| September 30, 2024 | 30.29M |
| June 30, 2024 | 35.59M |
| March 31, 2024 | 39.73M |
| December 31, 2023 | 43.65M |
| September 30, 2023 | 47.77M |
| June 30, 2023 | 51.43M |
| Date | Value |
|---|---|
| March 31, 2023 | 55.51M |
| December 31, 2022 | 58.84M |
| September 30, 2022 | 62.16M |
| June 30, 2022 | 66.38M |
| March 31, 2022 | 68.40M |
| December 31, 2021 | 73.95M |
| September 30, 2021 | 77.61M |
| June 30, 2021 | 82.43M |
| March 31, 2021 | 82.50M |
| December 31, 2020 | 20.36M |
| September 30, 2020 | 22.49M |
| June 30, 2020 | 25.61M |
| March 31, 2020 | 1.038M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.82M |
| Shareholders Equity (Quarterly) | -3.217M |
| Debt to Equity Ratio | -0.0123 |
| Current Ratio | 1.957 |
| Net Debt Paydown Yield | 0.06% |